Saudi Arabia has officially launched the world’s first AI clinic without human doctors; a move that redefines the traditional healthcare model and signals a step into the future of medicine. Located in the eastern province of Al Ahsa, the clinic opened its doors in April 2025 and has already begun offering consultations powered entirely by artificial intelligence. Dubbed the World’s First AI Clinic, the project stems from a landmark partnership between the Shanghai-based tech firm Synyi AI and Saudi Arabia’s Almoosa Health Group.
At the heart of this innovation is an AI-powered virtual physician named “Dr. Hua,” a system that brings years of machine learning and clinical data to life through tablet-based consultations. Patients interact with Dr. Hua by inputting their symptoms into a device, which prompts the AI to ask follow-up questions, assess data such as ECGs and X-rays, and generate a treatment plan tailored to the patient’s condition. While there are no human doctors present during the actual consultation, each treatment plan is reviewed and approved by a licensed physician, ensuring medical oversight remains part of the process.
Dr. Hua represents more than just a digital assistant—it’s a fully functioning diagnostic engine; this clinic marks Synyi AI’s first venture outside of China, where the company has established a strong track record since 2016, collaborating with over 800 hospitals and medical institutions. According to Synyi CEO Zhang Shaodian, this new venture moves beyond traditional AI support roles, allowing artificial intelligence to assume the responsibilities of diagnosing and prescribing treatment directly.
Despite operating without a live human doctor in the room, Dr. Hua boasts impressive accuracy. Internal tests have shown an error rate of less than 0.3%, a level of precision that rivals even seasoned professionals. Currently, the AI system is limited to diagnosing and managing 30 respiratory conditions, including common illnesses like asthma and pharyngitis. However, developers plan to expand its capabilities significantly within a year to cover around 50 diseases across respiratory, gastrointestinal, and dermatological categories.
The clinic is presently offering its services free of charge during the trial phase; this approach not only introduces patients to the AI-driven model but also allows for the collection of diagnostic data that will be crucial for evaluation by Saudi Arabia’s health regulators. However; the full-scale commercial deployment of the clinic is expected to follow once it secures the necessary approvals.
Looking ahead, Synyi AI and Almoosa Health Group aim to roll out this model across more hospitals in Saudi Arabia and extend it into neighboring countries throughout the Middle East. If successful, this expansion could mark the beginning of a new era in healthcare—one where AI clinics operate independently to deliver efficient, accurate, and accessible care to communities around the world.
Read more: Pig Kidney Transplant Recipient Recovering Well, US Hospital Reports
